hims semaglutide review & Hers falls 8% as FDA issues warning letter over compounded weight loss drug Hims cancels plans to sell

Get GLP-1 support alongside your TRT Talk to your Leger clinician or contact our team to find out if GLP-1 therapy can help you lose weight and get more from TRT

So the commonly cited regain curves reflect a very specific scenario: Sudden withdrawal of potent appetite-regulating therapy Removal of dietary, physical activity, and behavioral scaffolding that supported weight loss during the trial phase That combination almost guarantees weight regain and tells us more about biology plus trial design than about real-world inevitability

They are more likely to be covered by Medicare Part D plans and by commercial insurers for diabetes patients

it is only accessible through approved clinical trials, with phase 3 results still awaited as of 2025

Ignoring Regulatory Status: Researchers must maintain full awareness of professional compliance guidelines